Founded in 2024 in the United States by a team of PhD biochemists and veterinarians. The test is researched, developed, and manufactured in the US — then shipped to camel-producing regions worldwide.
Across the GCC, East Africa, and Australia, more than 35 million camels are managed by herders who confirm pregnancy by visual observation, palpation, or a day-long round trip to the nearest ELISA lab.
The value of the test isn't a new target or a different day — it's the same answer, in the same field visit, with a couple of drops of whole blood. No lab, no centrifuge, no waiting three days.
We make a single product, and we make it well.
Every design decision begins with the herder in 40°C heat, two hours from the nearest lab.
We will publish our validation data openly. Specificity and sensitivity will be independently verifiable, not just marketed.
Veterinary scientists and protein biochemists.
Dr. Nasef holds a Ph.D. from the University of Alabama and brings over 12 years of advanced R&D experience in biochemistry and diagnostics. He is the author of 8 peer-reviewed publications with more than 100 citations, and has designed and validated diagnostic platforms including lateral flow assays (LFA) and LC-MS/MS methods for testosterone quantification and drugs-of-abuse screening.
Dr. Nasef holds an MSc. from University College Dublin, Ireland, and is co-author of 11 peer-reviewed publications. He brings over 9 years of specialised veterinary experience with camels across the UAE, Saudi Arabia, and Qatar, with deep expertise in advanced reproductive technologies including embryo transfer and artificial insemination. He currently oversees a professional camel breeding operation of more than 1,000 animals in the UAE.
